Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
EVFM•Source information
Source text: ID:nBw1tpTGBa
Further company coverage: EVFM.PK
Additional manufacturing capacity for Phexx
Sept. 24 (Reuters) - Evofem Biosciences Inc EVFM.PK:
- Evofem Biosciences adds additional manufacturing capacity for Phexx® to support global growth strategy
- Evofem Biosciences - to submit sNDA to FDA for Phexx in mid-2027
- Evofem Biosciences - additional manufacturing source expected to reduce unit costs by 40% or more
Related News
Granite Point Mortgage Trust Announces Review Of Alternatives To Enhance Stockholder Value And 1-For-10 Reverse Stock Split
GPMT•
AIAI director Eric Affeldt reports purchase of 42,857 common shares worth $150,000
AIAI•
